INVESTORS & MEDIA

Corporate Governance

Corporate Governance

Date Name Title Type Shares Traded Price
Dec 13, 2018
Director, President & CEO
Director, President & CEO Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 187,500 $16.80
Dec 13, 2018
Director, President & CEO
Director, President & CEO Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 187,500 --
Dec 13, 2013
Director, President & CEO
Director, President & CEO Grant, award or other acquisition pursuant to Rule 16b-3(d) 187,500 --
Dec 14, 2012
Director, President & CEO
Director, President & CEO Grant, award or other acquisition pursuant to Rule 16b-3(d) 187,500 --
Dec 08, 2009
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 187,500 $8.77
Dec 08, 2009
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 187,500 --
Dec 17, 2008
Director, President & CEO
Director, President & CEO Grant, award or other acquisition pursuant to Rule 16b-3(d) 187,500 --
Oct 30, 2015
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 182,818 $11.64
Oct 30, 2015
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 182,818 --
Dec 19, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Grant, award or other acquisition pursuant to Rule 16b-3(d) 182,818 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

IR Tools